StimRelieve LLC, a privately held medical device company, today announced that it has received FDA Investigational Device Exemption (IDE) approval to launch a clinical trial of the world’s smallest percutaneously implantable device for the treatment of chronic migraine refractory to more conservative therapies such as NSAIDs, migraine-specific drugs, or combination drug therapy. The StimRelieve Halo Migraine System uses wirelessly-powered neurostimulators leveraging nanotechnology for the treatment of chronic migraines.
Estrogen is a tiny molecule, but it can have big effects on humans and other animals. Estrogen is one of the main hormones that regulates the female reproductive system - it can be monitored to track human fertility and is sometimes administered to livestock like cows and sheep to control the reproductive cycle.
Teledyne DALSA, a Teledyne Technologies company and global leader in digital X-Ray image sensing technology, will introduce its CMOS X-Ray detector for mammography at the RSNA 2015 Technical Exhibition, November 29 to December 3, at McCormick Place in Chicago. The complete portfolio of dynamic detectors for diagnostic and interventional imaging will be on display in the South Hall, Booth 3135.
Ultrasound, a non-invasive technique commonly used to study the presence of atherosclerosis disease in blood vessels, can be used to identify patients at increased risk of future stroke who could benefit from surgery. Since surgical treatment to prevent stroke is only considered beneficial to some, ultrasound can prove useful in preventing unnecessary surgical intervention, new research at Umeå University in Sweden shows.
Molecular Dynamics will present its revolutionary whole body CZT digital SPECT/CT solution at the upcoming 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) taking place in Chicago on Nov-29th through Dec-4th, in Booth 1122, Hall A.
ams, a leading worldwide provider of high-performance sensor and analog solutions, has entered into an agreement to acquire 100% of the shares in CMOSIS, a leader in advanced area and line scan CMOS image sensors for high-end imaging applications, in an all-cash transaction.
Using technology invented at MIT, doctors may one day be able to monitor patients’ vital signs by having them swallow an ingestible electronic device that measures heart rate and breathing rate from within the gastrointestinal tract.
Cambrios Technologies, the Sunnyvale, CA-based leader in silver nanowire technology, today announced its ClearOhm® silver nanowire-based flexible sensor made by Netherlands-based Claymount, are being used in a first-of-its-kind mammogram product from Amsterdam-based Sigmascreening.
InvenSense, Inc., a leading provider of MEMS sensor platform solutions, announced Coursa Sports, a cloud-based Software as a Service (SaaS) fitness tracking platform for smartphone and smartwatch health and fitness applications. The platform is designed to provide more accurate and always available speed, distance, and route tracking and at least a 3X improvement in relative elevation reporting for walking, hiking and running at up to 50% reduced power consumption.
The project was recognized as one of the 10 most outstanding creations among innovators under 35 delivered by the MIT Tech Review.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.